Matt (@nvestmattallen) 's Twitter Profile
Matt

@nvestmattallen

Insights on Investing Education & Growth Stocks | As Seen in Yahoo Finance and Bloomberg

ID: 462262407

linkhttp://stan.store/investmattallen calendar_today12-01-2012 19:14:53

255 Tweet

138 Followers

3,3K Following

Matt Allen (@investmattallen) 's Twitter Profile Photo

The Stock Market Mastery Bundle is here. If you’re ready to level up your investing, don’t miss this. Get access now: stan.store/investmattalle…

Money Coach Joe (@fisavvy) 's Twitter Profile Photo

Inflation = silent THEFT. Every day your cash sits still... It’s quietly losing value. Don’t let your money shrink. Invest it. Grow it. Protect your future.

Matt Allen (@investmattallen) 's Twitter Profile Photo

If a creator/influencer/famous person has a content business on auto-pilot there is a good chance that it will become normal for an AI clone version of this person to keep the business going even after the person dies They would just need one person to run it behind the scenes

Matt Allen (@investmattallen) 's Twitter Profile Photo

Rein Therapeutics $RNTX just dosed the first patient in a Phase 2 trial for a new treatment targeting IPF, a serious lung disease with limited options today. Their drug works in a brand-new way and has Orphan Drug status, which gives benefits for rare disease treatments. Check

Art of Rise (@art0frise_) 's Twitter Profile Photo

You're not chasing money - you're chasing freedom. Stick with me and let's build the kind of life you won't need a vacation from.

Matt Allen (@investmattallen) 's Twitter Profile Photo

$RNTX is a biotech company working on new treatments for rare lung diseases. They just kicked off a Phase 2 trial for their lead drug aimed at IPF, a life-threatening condition with few options. With early promise and FDA support, Rein is one I am watching.

Matt Allen (@investmattallen) 's Twitter Profile Photo

The reply bots on X are totally out of control and the worst it has ever been Elon Musk can literally create rockets that fly themselves to the moon and land themselves but can’t fix the bots

Matt Allen (@investmattallen) 's Twitter Profile Photo

This is very bullish for growth stocks. The market is risk-off. When we get rate cuts, and the trade war dies down then this capital will get deployed.

Matt Allen (@investmattallen) 's Twitter Profile Photo

Nexgel $NXGL is a company using hydrogel technology to improve how medicine is delivered through the skin. Their products are already FDA-cleared and sold in major stores. With a small share count, growing revenue, and strong IP, $NXGL is a unique biotech to keep on your radar.